Botulinum Toxin for the Management of Chronic Orchialgia
CompletedPhase 2NCT02058836
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this research study is to determine if Botox injections will provide relief from chronic testicular pain. In the study, the spermatic cord of particpants will be injected with either Botox or a placebo of saline. Botox is currently used to treat other urological conditions like overactive bladder and lower urinary tract problems. For these conditions, Botox works by relaxing muscles in the affected areas. The investigators believe that Botox will act similarly in the treatment chronic testicular pain.
Study details
- Official title
- Botulinum Toxin for the Management of Chronic Orchialgia
- Conditions
- Chronic Testicular Pain
- Interventions
- Drug: Botox Injection
- Procedure: Normal saline injection
- Sponsor
- Wake Forest University Health Sciences
- Collaborators
- Allergan
- Start date
- 2014-11
- Primary completion
- 2016-10-18
- Sex
- Male
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Clinical diagnosis of chronic testicular pain (orchialgia) Exclusion Criteria: * Active infection of urinary tract (UTI) * Active infection of the scrotal skin of the affected side * Bilateral orchiectomy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02058836